Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Recommended Global Infectious Diseases Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

COVID-19 Congress

About Conference


A Global Conversation on how we Act!
 
Viruses do not respect borders. In order to contain COVID-19, we must come together as a global community. ConferenceSeries LLC is convening a worldwide conversation to identify the best ideas, innovations, and solutions to eradicate this pandemic completely and globally.
 
As fears of the coronavirus pandemic continue to spread around the world, we will host an unprecedented online summit to illuminate the early lessons we can learn about this pandemic — and explore specific plans of action to address it.​
 
Beginning on Friday, June 11, the COVID-19 Summit will bring together speakers from a wide range of disciplines, including health experts, policymakers and business leaders for more than 8 hours of debate and discussion related to the virus and its global impact. The summit will will be a hybrid event, consisting of a small in-person gathering and a digital conference experience. Together, we will discover the latest information, share successes, debate tough choices and imagine a future that is more resilient, more connected, kinder and healthier than ever before.

Purpose

The coronavirus has become far more than just a public health issue. Its effects are far reaching - from its impact on the global economy and industries such as sport, travel, entertainment and events, to its social, physiological and racial implications. Although we cannot be physically together at this time, it is important that we come together as a global community through other means. We need new strategies and systems in place in order to remain agile in times of uncertainty and radical change, such as these. Through shared discourse and debate, we can develop best practices to come out of this global and domestic crisis smarter, stronger and more resilient.​
 
The Summit will uncover the complexity of this global virus, it will underscore the values we need to live by as a global community, and will provide concrete strategies, solutions and best practices for how to mitigate the effects of this issue and other global and local crises in the future.

Major Sessions

 
Coronavirus (COVID-19) is a zoonotic disease. Zoonotic diseases are transmitted between creatures and humans. Diseases transmitted from animals to humans pose a significant threat to human health. COVID-19 is a reminder that human health and environmental health are closely related. There are about 8 million species of living things on earth, of which humans are just one. These include 1.7 million undetected viruses that are known to infect humans in mammals and waterfowl. If we do not take preventive measures now, any one of these will be transferred to humans. Greenhouse gas emissions — primarily caused by the burning of fossil fuels — cause changes in temperature and humidity that directly affect microbial survival.

Patients with suspicious common clinical signs of Kovid-19 such as fever, cough, sore throat, loss of taste or smell, malaise and myalgia should be tested immediately for SARS-CoV-2. In addition to symptomatic patients, patients with typical symptoms of Kovid-19 or anyone with high-risk exposure to SARS-CoV-2 should be tested for SARS-CoV-2 infection even if they have no symptoms.

 
 
In patients with COVID-19, white blood cell count may vary between leukopenia, leukocytosis, and lymphopenia, although lymphopenia is more common. In particular, an increase in the number of lymphocytes in COVID-19 was associated with increased disease severity. Lymphopenia and low lymphocyte counts indicate poor prognosis in COVID-19 patients. The causes and mechanisms of lymphopenia in Kovid-19 patients are unknown but SARS-like viral cells and SARS-CoV RNA were found in T cells, indicating the direct effect of SARS virus on T cells by apoptosis. During SARS-CoV infection, antigen-presenting cell (APC) function is altered and priming of T cells decreases as a result of impaired DC migration.
The immune response to viral infections:
  1. Innate immune response
  2. Adaptive immune response
  • T-cells (cellular response)
  • B-cells (antibody response)
After infection, T and B-cells degenerate, but some "memory" cells enable a more rapid response. The virus was encountered a second time.
 
 
Corona viruses are a group of related RNA viruses that cause diseases in mammals and birds. In humans and birds, they can cause mild to fatal respiratory infections. The common cold is a common illness in humans (it is caused by other viruses, mainly rhinoviruses), but the more deadly types are SARS, MERS, and COVID-19, which cause an on-going pandemic. They cause diarrhea in cows and pigs, and hepatitis and encephalomyelitis in rats. Coronaviruses belong to the subfamily Orthochoronavirin, in the family Coronaviridae, a sequence of nidoviruses and the ribavirin kingdom. They are viruses covered with a positive-sense single-stranded RNA gene and a nucleocapsid helical symmetry.

Important considerations for Contact tracing:

Contact is a person who is likely to get an infection from a positive case through any known transmission methods. If someone has a Covid-19 symptom, 2 to 14 days before the symptoms appear unless previously isolated. For asymptomatic or pre-symptomatic cases, the duration for contact tracing is taken from 2 days to 14 days after the date if not separated before sample collection.

 
The Covid-19 epidemic showed how vulnerability in health systems can have a profound effect on health, economic progress, trust in governments, and social cohesion. Having and reducing the virus spread and infection rate is very important. But is strengthening the ability of health systems to respond quickly and effectively. This includes administering the COVID-19 vaccine. The long-term effects of COVID-19 are already beginning to emerge: the behavioural health number of anxiety and depression related to the virus, the extended lockdown and subsequent recession.
 
Air Quality
Chemical Safety
Hepatitis
Water and Sanitation
Immunization
 
 
A Combination of Impacts of Large economic RECESSION and Major food system DISRUPTIONS. Covid-19 affects the food and nutrition security of poor people unequally: they spend most of their income on food. Their main productive factor and property is physical activity. Covid-19 causes more disruptions in their (private) food value chains because it is more labor-intensive. Interruption to public social and nutrition programs. Preliminary estimates suggest that hundreds of thousands of people could die and millions will starve without a concerted effort to address food security issues. By October 2020, these efforts had reduced the risk of widespread starvation due to the COVID-19 pandemic. Droughts have caused panic as a result of the COVID-19 depression and some measures taken to prevent the spread of COVID-19
 
 
Fear, anxiety, and stress are normal responses to perceived or real threats and sometimes when we encounter uncertainty or the unknown. So it is common and understandable that people are experiencing fear in the wake of the COVID-19 pandemic. Since the onset of the COVID-19 epidemic, unemployment and economic instability, disruption to education, social loneliness, fear of close partner and family violence, fear of life-threatening illness, and sudden loss of loved ones are all too common. All of these are risk factors for mental health conditions and behavioral problems such as depression and substance abuse disorders.

In addition to the fear of contracting a virus in an epidemic such as COVID-19, significant changes are made in our daily lives as our movements are restricted in support of efforts to stop and slow the spread of the virus. When faced with new realities such as working from home, temporary unemployment, having children at home, and not having physical contact with other family members, friends, and co-workers, we need to manage our mental, as well as our physical health.

  • Bereavement
  • Isolation
  • Loss of income
  • Insomnia
  • Drug use
  • Harmful alcohol
  • Suicidal behaviour
 
The COVID-19 pandemic is far greater than the health crisis: it is affecting societies and economies at their core. The impact of the pandemic varies from country to country, increasing global poverty, and inequality, making the practice of SDGs even more urgent. Assessing the impact of the COVID-19 crisis on societies, economies and vulnerable groups is fundamental to informing and shaping the responses of governments and partners to recovering from the crisis and to verifying that no one is left behind in this endeavour. Without immediate socio-economic responses, global suffering will escalate, putting lives and livelihoods at risk in the years to come. Immediate development responses to this crisis must be undertaken with a view to the future. Long-term development trajectories are affected by the choices countries make now and the support they receive
Although all businesses and sectors were affected by the epidemic, the sector was severely affected by reduced cash flow, supply chain disruptions, shortage of migrant workers due to reverse migration, low demand and so on.
 

Equal access to safe and effective vaccines is crucial to ending the COVID-19 epidemic, so many vaccines are very encouraging to prove and develop. The WHO is working tirelessly with partners to develop, manufacture and implement safe and effective vaccines. Safe and effective vaccines are a game changer: in the future, however, we must wear masks, wash our hands, ensure good ventilation inside the home, avoid physical contact, and avoid crowds. Vaccination does not mean that we can take care of the air and endanger ourselves and others; especially that research is still on going on how vaccines can protect us not only from disease but also from infection and transmission.

Vaccines save millions of lives each year and the COVID-19 vaccine can save your life. COVID-19 vaccines are safe and effective, providing strong protection against serious illness and death. COVID-19 vaccines are highly effective, but no vaccine provides 100% protection. Some people become infected with Covid-19 even after being vaccinated, while others become infected with the virus.

 
Viruses such as SARS-CoV-2 are constantly evolving due to changes in the genetic code (genetic mutations) that occur during replication of the gene. A genus is a genetically closely related group of virus variants that originate from a common ancestor. One variant has one or more mutations that distinguish it from other variants of SARS-CoV-2 viruses.
  • Variant Being Monitored (VBM):  Alpha (B.1.1.7 and Q lineages), Beta (B.1.351 and descendent lineages), Gamma, Epsilon, Eta, Iota, Zeta
  • Variant of Interest (VOI)
  • Variant of Concern (VOC): Delta, Omicron
  • Variant of High Consequence (VOHC)
 
Most people who develop Kovid-19 will fully recover, but current evidence suggests that approximately 10% -20% of people experience a variety of intermediate and long-term effects after redeeming from their initial illness. These intermediate and long-term effects are collectively known as the post-COVID-19 condition or "long covid", refers to a combination of chronic symptoms that some people experience after having Kovid-19. People who experience the condition after COVID-19 sometimes call themselves "long-haulers". These symptoms can continue from their initial illness or develop after their recovery. They may come and go over time or come back. The condition after COVID-19 affects a person's ability to perform daily activities such as work or household chores.

Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) damages the lungs, brain, blood vessels, skin, nerves, kidneys, and heart, increasing the risk of chronic health problems. However, the virus can remain in the body for up to 3 months after diagnosis. This means that some people will get a second positive test result even after recovery, although this does not necessarily indicate that the virus is still contagious.

 
The COVID-19 pandemic disrupted education systems around the world, making it extremely vulnerable to learners. This has exacerbated inequalities and exacerbated the pre-existing educational crisis. School closures last longer than the full academic year as they are not closed in some countries. At least one-third of students are excluded from learning remotely due to lack of connectivity and equipment. In general, low education options have an impact on low-income people worldwide, while high-income people have found education. New online programs have shifted the burden of education from schools to families and individuals and as a result, people everywhere who rely on schools rather than computers and home life have had more difficulty acquiring their education.
 
Today, despite the Omicron variant, schools are open in most countries with support for health and safety protocols and vaccination programs. But in terms of learning losses, health and well-being and drop-out costs are enormous. It is important to prioritize education as a public good in order to prevent disaster for generations and to drive sustainable recovery. To be more resilient, equitable and inclusive, education systems must transform, use technology to benefit all learners and build catalytic innovations and partnerships throughout this crisis.
  • Implement learning recovery programs
  • Protect the education budget
  • Prepare for future shocks by building back better

To Collaborate Scientific Professionals around the World

Conference Date July 11-12, 2022

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Supported By

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by